Alerts
PDF
Other content recommended for you
- Sham surgery controls are mitigated trolleys
- Sham neurosurgery in patients with Parkinson's disease: is it morally acceptable?
- Benefits, risks and ethical considerations in translation of stem cell research to clinical applications in Parkinson’s disease
- Unilateral pallidotomy for Parkinson’s disease: results after more than 1 year
- Pramipexole in patients with Parkinson's disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre study
- Finnish Degenerative Meniscal Lesion Study (FIDELITY): a protocol for a randomised, placebo surgery controlled trial on the efficacy of arthroscopic partial meniscectomy for patients with degenerative meniscus injury with a novel ‘RCT within-a-cohort’ study design
- Data-driven evolution of neurosurgical gene therapy delivery in Parkinson’s disease
- Sham surgery can be ethical and safe
- Comparison of patient rated treatment response with measured improvement in Parkinson's disease
- Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson’s disease: a double blind, placebo controlled, randomised, multicentre study